Dianthus Therapeutics
DNTH
DNTH
94 hedge funds and large institutions have $217M invested in Dianthus Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 16 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
-1
Holders Change %
-1.05%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
17
Increased
34
Reduced
16
Closed
18
Calls
$3K
Puts
$89K
Net Calls
-$86K
Net Calls Change
+$27K
Top Buyers
| 1 |
ACM
Aquilo Capital Management
San Francisco,
California
|
$6.52M |
| 2 |
Two Sigma Advisers
New York
|
$1.27M |
| 3 |
Two Sigma Investments
New York
|
$1.27M |
| 4 |
BlackRock
New York
|
$12M |
| 5 |
Renaissance Technologies
New York
|
$2.47M |
